- Home
- CTSH vs EW Comparison
CTSH vs EW Comparison
Compare CTSH & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSH
- EW
- Stock Information
- Founded
- CTSH 1994
- EW 1958
- Country
- CTSH United States
- EW United States
- Employees
- CTSH N/A
- EW N/A
- Industry
- CTSH EDP Services
- EW Industrial Specialties
- Sector
- CTSH Technology
- EW Health Care
- Exchange
- CTSH Nasdaq
- EW Nasdaq
- Market Cap
- CTSH 43.6B
- EW 42.5B
- IPO Year
- CTSH 1998
- EW 2000
- Fundamental
- Price
- CTSH $84.87
- EW $73.50
- Analyst Decision
- CTSH Hold
- EW Buy
- Analyst Count
- CTSH 19
- EW 21
- Target Price
- CTSH $83.67
- EW $79.95
- AVG Volume (30 Days)
- CTSH 3.6M
- EW 4.3M
- Earning Date
- CTSH 02-05-2025
- EW 02-11-2025
- Dividend Yield
- CTSH 1.45%
- EW N/A
- EPS Growth
- CTSH 7.13
- EW 202.97
- EPS
- CTSH 4.51
- EW 6.97
- Revenue
- CTSH $19,736,000,000.00
- EW $5,439,500,000.00
- Revenue This Year
- CTSH $7.95
- EW $10.34
- Revenue Next Year
- CTSH $6.13
- EW $10.65
- P/E Ratio
- CTSH $18.92
- EW $10.52
- Revenue Growth
- CTSH 1.98
- EW N/A
- 52 Week Low
- CTSH $63.79
- EW $58.93
- 52 Week High
- CTSH $90.82
- EW $96.12
- Technical
- Relative Strength Index (RSI)
- CTSH 51.75
- EW 54.14
- Support Level
- CTSH $81.84
- EW $70.10
- Resistance Level
- CTSH $90.82
- EW $76.73
- Average True Range (ATR)
- CTSH 1.84
- EW 1.24
- MACD
- CTSH -0.13
- EW 0.30
- Stochastic Oscillator
- CTSH 36.57
- EW 56.94
About CTSH Cognizant Technology Solutions Corporation
Cognizant is a global IT services provider, offering consulting and outsourcing services to some of the world's largest enterprises spanning the financial services, media and communications, healthcare, natural resources, and consumer products industries. Cognizant employs nearly 350,000 people globally, roughly 70% of whom are in India, although the company's headquarters are in Teaneck, New Jersey.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.